Synapse - Find an Expert

33620 Results

ECOG-ACRIN tomosynthesis mammographic imaging screening trial (EA1151)

Meeting Abstract

Pisano, E.; Gatsonis, C.; Yaffe, M.; Troester, M.; Gareen, I. F.; Collins, L. C.; Curtis, A.; Cole, E.; Carlos, R.; Miller, K.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

A phase I/II clinical trial of the reversible LSD1 inhibitor, seclidemstat, in patients with relapsed/refractory Ewing sarcoma

Meeting Abstract

Reed, D. R.; Mascarenhas, L.; Meyers, P. A.; Chawla, S. P.; Harrison, D. J.; Setty, B.; Metts, J.; Wages, D. S.; Stenehjem, D. D.; Santiesteban, D. Y.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status

Meeting Abstract

Ricciuti, B.; Arbour, K. C.; Lin, J. J.; Vokes, N.; Hoojghan, A. V.; Li, Y. Y.; Cherniack, A. D.; Recondo, G.; Lamberti, G.; Venkatraman, D.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Error-free, automated data integration of exosome cargo protein data with extensive clinical data in an ongoing, multi-omic translational research study

Meeting Abstract

Oromendia, A.; Ismailgeci, D.; Ciofii, M.; Donnelly, T.; Bojmar, L.; Jyazbek, J.; Chatterjee, A.; Lyden, D.; Yu, K. H.; Kelsen, D. P.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

A phase III trial of docetaxel versus docetaxel and radium-223 (Ra-223) in patients with metastatic castration-resistant prostate cancer (mCRPC): DORA

Meeting Abstract

Morris, M. J.; De Wit, R.; Vogelzang, N. J.; Tagawa, S. T.; Higano, C. S.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Phase I study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting DLL3, in patients with small cell lung cancer (SCLC)

Meeting Abstract

Owonikoko, T. K.; Borghaei, H.; Champiat, S.; Paz-Ares, L. G.; Govindan, R.; Boyer, M. J.; Johnson, M. L.; Udagawa, H.; Hummel, H. D.; Salgia, R.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Technology-enabled longitudinal monitoring of patient-reported outcomes (PROs) to individualize care of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ICIs)

Meeting Abstract

Msaouel, P.; Van Alstine, M. L.; Oromendia, C.; Gao, J.; Wang, Y.; Siddiqui, B. A.; Siefker-Radtke, A. O.; Shah, A. Y.; Shaw, L.; Lopez, L.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Automated identification of lymphoma involving the bone from PET/CT reports using natural language processing and adaptive learning

Meeting Abstract

Navitski, A.; Goyal, P.; Ahsanuddin, S.; Zheng, S.; Joffe, E.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Locoregional control, failure patterns and clinical outcomes in patients with stage III non-small cell lung cancers treated with chemoradiation and durvalumab

Meeting Abstract

Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A.; Simone, C. B.; Gelblum, D. Y.; Wu, A. J. C.; Lee, N. Y.; Kris, M. G.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

INDIGO: A global, randomized, double-blind, phase III study of vorasidenib (VOR; AG-881) vs placebo in patients (pts) with residual or recurrent grade II glioma with an isocitrate dehydrogenase 1/2 (IDH1/2) mutation

Meeting Abstract

Mellinghoff, I. K.; Van den Bent, M. J.; Clarke, J. L.; Maher, E. A.; Peters, K. B.; Touat, M.; De Groot, J. F.; De La Fuente, M. I.; Arrillaga-Romany, I.; Wick, W.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

33620 Results

People

Groups

Results (33620)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract